Frontlight ResearchEarly access
Rheumatoid arthritis trials in France
29 of 49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Where
- Marseille, Montpellier, Paris, Strasbourg, Toulouse
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07137598 - Phase 2Taking peopleAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Where
- Marseille, Montpellier Cedex 5, Paris, Strasbourg Cedex 2, Toulouse
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00 - No phaseNot yet taking people in FranceSmall Airway Dysfunction in Rheumatoid Arthritis and Systemic Sclerosis
- Where
- Paris
- Age
- 18 years and over
- People
- 184
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07924124 - Phase 1/2Not yet taking people in FrancePhase 1/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SAR447998 in adults with refractory Systemic Lupus Erythematosus or Rheumatoid Arthritis
- Where
- Marseille, Montpellier Cedex 5, Pessac
- Age
- 18 years and over
- People
- 10
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2026-526117-28-00 - Phase 2Not yet taking people in FranceFunctional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear Medicine
- Where
- Clermont-Ferrand
- Age
- 18 years and over
- People
- 80
- Run by
- Centre Jean Perrin
See details and how to joinNCT07624994 - Phase 1Taking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Bordeaux, Montpellier, Nancy, Paris, Strasbourg Cedex 2, Toulouse Cedex 9
- Age
- 18 years to 70 years
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - Phase 1Not yet taking people in FranceA Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
- Where
- Montpellier, Paris
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07873931 - Phase 2Taking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Le Kremlin-Bicêtre, Lille, Lyon, Lyon Cédex 3, Marseille, Paris, Strasbourg, Toulouse
- Age
- 18 years to 75 years
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
- Where
- Marseille, Montpellier Cedex 5, Paris, Strasbourg Cedex 2, Toulouse
- Age
- 18 years and over
- People
- 89 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2025-521034-28-00 - Phase 1Not yet taking people in FranceStudy Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
- Where
- Villejuif
- Age
- 18 years to 75 years
- People
- 6
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07544225 - Phase 1Taking peopleA Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Where
- Montpellier, Strasbourg Cedex 2
- Age
- 18 years to 75 years
- People
- 36 worldwide
- Run by
- AbbVie
See details and how to joinNCT06977724 · EU 2024-519157-10-00 - Phase 4Taking peopleJAK Inhibitor Dose TAPering Strategy Study
- Where
- Amiens Cedex 1, Bordeaux, Brest Cedex 2, Chambray Les Tours, Clermont Ferrand Cedex 1, Le Kremlin-Bicetre, Le Mans Cedex 9, Limoges, Lomme Cedex, Marseille, Montpellier Cedex 5, Nice, Orleans Cedex 2, Paris, Paris Cedex 10, Paris Cedex 13, Paris Cedex 14, Reims, Rouen Cedex, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy Cedex
- Age
- 18 years to 65 years
- People
- 308
- Run by
- University Hospital, Toulouse
See details and how to joinNCT06687551 · EU 2023-509788-25-00 - Phase 2CompletedAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Marseille, Montpellier, Toulouse Cedex 9
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - Phase 2Not yet taking people in Francefunctional imaging of digital osteoarthritis and rheumatoid arthritis using 99mTc-NTP15-5 in nuclear medicine : phase II clinical study
- Where
- Clermont-Ferrand
- Age
- 18 years and over
- People
- 80
- Run by
- Centre Jean Perrin
See details and how to join2025-523650-14-00 - Phase 1Taking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Lille Cedex, Strasbourg Cedex 2
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - No phaseTerminatedClinical Outcomes Study of the Nexel Total Elbow
- Where
- Toulouse
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Zimmer Biomet
See details and how to joinNCT02469662 - Phase 1Taking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Bordeaux, Toulouse Cedex 9
- Age
- 18 years to 70 years
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - No phaseTaking peopleInsole Optimization for Rheumatoid Arthritis Patients
- Where
- Saint-Etienne
- Age
- 18 years and over
- People
- 10
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT07321340 - Phase 4Not yet taking people in FranceTdose Binding and Tocilizumab
- Where
- Marseille, Nice
- Age
- 18 years and over
- People
- 122
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07582185 · EU 2025-522319-41-00 - Phase 1Not yet taking people in FranceA phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid arthritis (RA)
- Where
- Brest, Le Kremlin Bicetre Cedex, Paris
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-520196-27-00 - No phaseTaking peopleEffects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis
- Where
- Besançon
- Age
- 50 years and over
- People
- 90
- Run by
- Jérôme Bouchan
See details and how to joinNCT07469540 - Phase 4Taking peopleDesign and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
- Where
- Caluire-et-Cuire, Chambray Les Tours, La Roche Sur Yon Cedex 9, Lomme Cedex, Montpellier Cedex 5, Paris Cedex 13, Reims Cedex, Saint-Priest-en-Jarez
- Age
- 18 years and over
- People
- 180
- Run by
- Centre Hospitalier Universitaire de Saint Etienne
See details and how to joinNCT06528431 · EU 2024-514313-35-00 - No phaseTaking peopleThe Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.
- Where
- Clermont-Ferrand
- Age
- 18 years to 50 years
- People
- 396
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT06426316 - Phase 3Taking peopleEfficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
- Where
- Bordeaux Cedex, Brest Cedex 2, Caen Cedex 9, Cahors, La Roche Sur Yon Cedex 9, Le Kremlin Bicetre Cedex, Le Mans Cedex 9, Lomme Cedex, Montfermeil, Montpellier Cedex 5, Nantes Cedex 1, Nice, Nimes Cedex 9, Orleans Cedex 2, Paris, Strasbourg Cedex, Toulouse, Tours
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- University Hospital, Montpellier
See details and how to joinNCT05428488 · EU 2022-500234-29-00 - No phaseTaking peopleRhEumatoid Arthritis MEDIcation Adherence
- Where
- Lyon, Pierre-Bénite
- Age
- 18 years and over
- People
- 200
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT05413759